Contact us

Visualize a scientific publication and its results

    Why Medical Adviser`s Group?
    Quality
    All works are performed in accordance with generally accepted international recommendations for the creation of scientific medical content. are a leading firm in providing quality and value to our customers.
    Expertise
    The expertise of our employees is confirmed by the high-profile scientific journal New England Journal of Medicine
    Development
    Our company is a finalist of the international scientific contest SPRINT Data Analysis Challenge member of our team has at least 5 years of legal experience method allows us to achieve success in problems of all levels.
    Flexibility
    We have several scientific editors in our team who specialize in various therapeutic areas and several medical writers; thus, we can replace the specialist at any time, which ensures the project consistency

    Let's have a conversation

    We will get back in touch with you
     I agree to the terms and conditions and privacy policy
    • About us
    • Services
    • Medical writing
    • Trainings
    • Medical presentations
    • Data visualization
    Visual storytelling for medical publications
    2022-08-22 16:56

    Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

    #Mepolizumab reduced the number of exacerbations in #urban #children with exacerbation-prone eosinophilic #asthma, #MUPPITS2 study finds

    https://bit.ly/3plfXTy
    #VisualAbstract #DataViz #USA #eosinophilicasthma #in